Catalyst Wire Dossier Catalyst Wire Dossier

Lifitegrast ophthalmic solution 5%

lifitegrast · Shire (a Takeda company)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lifitegrast ophthalmic solution 5%, covering 2024-07-15 to 2024-07-15. Get the full timeline:

Most recent: Clinical Trial Update: The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease [EARLY_Phase 1]

See pricing